C118 - How to Understand and Incorporate Medical Cannabis into Clinical Practice

Event Time: Monday May 6, 2019 3:30 pm to 5:30 pm
Topic(s): Practice, Policy, and Ethics
Director(s): Laszlo Mechtler MD, FAAN, FASN
Description: Explosion of activity surrounding marijuana since the Dr. Sanjay Gupta CNN series. State legalization, breakthrough FDA decisions, enormity of popular press, and a long history of anecdotal evidence of its medicinal value despite its categorization as a Schedule I drug. Prospective research in the US has been restricted due the this designation, but retrospective and international studies have increasingly demonstrated opportunity in a wide range of Neurologic disorders. This course will provide an update on the current status of medical cannabis in the world and the US. Speakers will review the history of its medicinal use and ultimately reclassification to Schedule I, legal issues that are germane to potential research and clinical use, summarize different products available, and what an FDA approved purified CBD medication means to this topic.
Completion Message: Attendees should be able to understand the current status of Medical Marijuana, when and how to order/certify patients, and how to incorporate Medical Cannabis in the clinical practice of neurology to improve the quality of life of our patient population.
CME Credits: 2
Core Competencies: Patient Care, Interpersonal and Communication Skills, Medical Knowledge, Practice-Based Learning and Improvement

Ready to register for the 2019 AAN Annual Meeting?

Register Now

Related Courses